NO20033621L - Ny melkesyrebakteriestamme og spiselige sammensetninger, legemidler og veterin¶rprodukter inneholdende denne - Google Patents

Ny melkesyrebakteriestamme og spiselige sammensetninger, legemidler og veterin¶rprodukter inneholdende denne

Info

Publication number
NO20033621L
NO20033621L NO20033621A NO20033621A NO20033621L NO 20033621 L NO20033621 L NO 20033621L NO 20033621 A NO20033621 A NO 20033621A NO 20033621 A NO20033621 A NO 20033621A NO 20033621 L NO20033621 L NO 20033621L
Authority
NO
Norway
Prior art keywords
products containing
edible compositions
pharmaceuticals
lactic acid
bacterial strain
Prior art date
Application number
NO20033621A
Other languages
English (en)
Other versions
NO20033621D0 (no
NO329645B1 (no
Inventor
Claudio De Simone
Original Assignee
Actial Farmaceutica Lda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actial Farmaceutica Lda filed Critical Actial Farmaceutica Lda
Publication of NO20033621D0 publication Critical patent/NO20033621D0/no
Publication of NO20033621L publication Critical patent/NO20033621L/no
Publication of NO329645B1 publication Critical patent/NO329645B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/249—Thermophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/529—Infantis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)

Abstract

Det beskrives en ny stamme av Streptococcus thermoophilus ssp. Salivarius (deponert 4. desember 2001 ved DSMZ - Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Tyskland, med aksesjonsnr. DSM 14667) og spiselige sammensetninger, legemidler og veterinærprodukter inneholdende stammen. Anvendelsen av nevnte stamme er spesielt effektiv ved forebyggelse/behandling av hepatisk steatosis (fettlever) og ved ikke-alkoholisk hepatisk steatosis.
NO20033621A 2001-12-21 2003-08-14 Bakteriestamme, sammensetning og anvendelse av nevnte bakteriestamme NO329645B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001RM000763A ITRM20010763A1 (it) 2001-12-21 2001-12-21 Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
PCT/IT2002/000812 WO2003055984A1 (en) 2001-12-21 2002-12-19 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it

Publications (3)

Publication Number Publication Date
NO20033621D0 NO20033621D0 (no) 2003-08-14
NO20033621L true NO20033621L (no) 2003-08-14
NO329645B1 NO329645B1 (no) 2010-11-22

Family

ID=11455924

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20033621A NO329645B1 (no) 2001-12-21 2003-08-14 Bakteriestamme, sammensetning og anvendelse av nevnte bakteriestamme

Country Status (29)

Country Link
US (2) US7223591B2 (no)
EP (2) EP1456351B1 (no)
JP (2) JP4339124B2 (no)
KR (1) KR100934747B1 (no)
CN (2) CN100502893C (no)
AR (1) AR038036A1 (no)
AT (1) ATE335807T1 (no)
AU (1) AU2002367124B2 (no)
BR (1) BR0207397A (no)
CA (1) CA2457801C (no)
CY (1) CY1105402T1 (no)
DE (1) DE60213859T2 (no)
DK (1) DK1456351T3 (no)
EA (1) EA006688B1 (no)
ES (1) ES2271384T3 (no)
HK (2) HK1072958A1 (no)
HU (1) HU225787B1 (no)
IL (2) IL161995A0 (no)
IS (1) IS2645B (no)
IT (1) ITRM20010763A1 (no)
MA (1) MA27685A1 (no)
MX (1) MXPA03007483A (no)
NO (1) NO329645B1 (no)
NZ (1) NZ533696A (no)
PL (1) PL207395B1 (no)
PT (1) PT1456351E (no)
UA (1) UA80546C2 (no)
WO (1) WO2003055984A1 (no)
ZA (1) ZA200405763B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
US8697051B2 (en) * 1999-06-09 2014-04-15 Vsl Pharmaceuticals Inc. Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
ITRM20010763A1 (it) 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
US20050239706A1 (en) * 2003-10-31 2005-10-27 Washington University In St. Louis Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
CA2662710A1 (en) * 2006-09-07 2008-03-13 Mcgill University Oral polymeric membrane feruloyl esterase producing bacteria formulation
JP5203393B2 (ja) * 2008-01-15 2013-06-05 サッポロビール株式会社 アルコール性肝障害抑制剤
EP2411026A1 (en) 2009-03-25 2012-02-01 Chr. Hansen A/S Use of probiotics to ameliorate diet-induced insulin resistance
TW201106957A (en) * 2009-08-31 2011-03-01 Synbio Tech Inc The new strain of Lactobacillus plantarum LP28 and its use in treating allergy
CN102702372B (zh) * 2010-10-28 2013-11-27 内蒙古蒙牛乳业（集团）股份有限公司 一种嗜热链球菌胞外多糖及其制备和检测方法
KR101238836B1 (ko) 2011-05-17 2013-03-04 삼육대학교산학협력단 혼합 유산균을 포함하는 비만 또는 비만 관련 질환 치료 또는 예방용 약제학적 조성물 또는 식품 조성물
EP2609814A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of cognitive function
JP6061530B2 (ja) * 2012-07-25 2017-01-18 株式会社ヤクルト本社 Ｎａｓｈ予防治療剤
AU2013318513A1 (en) 2012-09-20 2015-04-09 Prothera Inc. Probiotic compositions and methods for the treatment of obesity and obesity-related conditions
KR101545551B1 (ko) 2013-12-12 2015-08-19 주식회사한국야쿠르트 인슐린 저항성 개선 효능을 갖는 7종의 유산균 복합균주를 유효성분으로 함유하는 조성물
KR101426275B1 (ko) 2014-04-04 2014-08-06 주식회사한국야쿠르트 지방합성 억제 및 지방산화 촉진에 의한 체지방 감소 효능을 갖는 5종의 유산균 복합균주를 유효성분으로 함유하는 조성물
CN106661542B (zh) * 2014-05-29 2020-07-10 日东药品工业株式会社 新型乳酸菌和包含所述乳酸菌的组合物
EP3172973B1 (en) * 2015-11-27 2020-04-08 DAFLORN Ltd. Probiotic formula, process of its preparation and use
WO2017178316A1 (en) * 2016-04-14 2017-10-19 Dupont Nutrition Biosciences Aps Bifidobacteria for reducing food, energy and/or fat intake
WO2018174125A1 (ja) * 2017-03-22 2018-09-27 雪印メグミルク株式会社 脂質代謝改善用組成物
KR102218992B1 (ko) 2017-12-12 2021-02-23 한국생명공학연구원 아가토바쿨룸 속 균주를 유효성분으로 함유하는 자폐 범주성 장애의 예방, 개선 또는 치료용 조성물
KR102021881B1 (ko) * 2018-09-07 2019-09-17 재단법인 전남생물산업진흥원 스트렙토코커스 써모필러스 lm1012 균주 및 이를 포함하는 염증 질환 또는 대사 질환의 예방 또는 치료용 조성물
CN113025527A (zh) * 2021-03-25 2021-06-25 上海市第十人民医院 一种用来预测婴幼儿肥胖病的乳源性唾液链球菌及其分离方法
CN115181698B (zh) * 2022-06-28 2023-09-08 广东粤港澳大湾区国家纳米科技创新研究院 一种益生菌组合物及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61221124A (ja) * 1985-03-26 1986-10-01 Advance Res & Dev Co Ltd 肝機能改善剤
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
US6297229B1 (en) * 1994-11-14 2001-10-02 Mayo Foundation For Medical Education And Research Use of ursodeoxycholic acid to treat nonalcoholic steatohepatitis
US5760010A (en) * 1995-01-01 1998-06-02 Klein; Ira Method of treating liver disorders with a macrolide antibiotic
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
MY117168A (en) 1997-12-05 2004-05-31 Viva America Marketing Inc Composition and method for treating nonalcoholic steatohepatitis
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
IT1309427B1 (it) * 1999-05-28 2002-01-23 Mendes S U R L Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
ITRM20010763A1 (it) 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.

Also Published As

Publication number Publication date
AR038036A1 (es) 2004-12-22
CN1875994A (zh) 2006-12-13
WO2003055984A1 (en) 2003-07-10
CA2457801A1 (en) 2003-07-10
EA006688B1 (ru) 2006-02-24
PL370252A1 (en) 2005-05-16
IS7229A (is) 2004-04-21
US7628981B2 (en) 2009-12-08
US7223591B2 (en) 2007-05-29
BR0207397A (pt) 2004-02-10
ES2271384T3 (es) 2007-04-16
NO20033621D0 (no) 2003-08-14
DE60213859D1 (de) 2006-09-21
HU225787B1 (hu) 2007-09-28
EP1456351A1 (en) 2004-09-15
CN1558946A (zh) 2004-12-29
ZA200405763B (en) 2006-07-26
CA2457801C (en) 2013-06-04
JP2009183296A (ja) 2009-08-20
MXPA03007483A (es) 2003-12-04
MA27685A1 (fr) 2006-01-02
US20070253934A1 (en) 2007-11-01
HUP0402460A3 (en) 2005-04-28
UA80546C2 (en) 2007-10-10
NZ533696A (en) 2005-12-23
JP4339124B2 (ja) 2009-10-07
IS2645B (is) 2010-08-15
US20040248278A1 (en) 2004-12-09
CN100502893C (zh) 2009-06-24
JP2005512590A (ja) 2005-05-12
AU2002367124A1 (en) 2003-07-15
CN1276970C (zh) 2006-09-27
AU2002367124B2 (en) 2007-11-29
KR20040074053A (ko) 2004-08-21
IL161995A0 (en) 2005-11-20
DK1456351T3 (da) 2006-12-11
NO329645B1 (no) 2010-11-22
HK1100165A1 (en) 2007-09-07
ATE335807T1 (de) 2006-09-15
PT1456351E (pt) 2006-10-31
ITRM20010763A1 (it) 2003-06-21
CY1105402T1 (el) 2010-04-28
IL161995A (en) 2010-11-30
EA200400845A1 (ru) 2004-12-30
HK1072958A1 (en) 2005-09-16
HUP0402460A2 (hu) 2005-03-29
EP1652913A1 (en) 2006-05-03
KR100934747B1 (ko) 2009-12-30
DE60213859T2 (de) 2007-02-08
EP1456351B1 (en) 2006-08-09
PL207395B1 (pl) 2010-12-31

Similar Documents

Publication Publication Date Title
NO20033621L (no) Ny melkesyrebakteriestamme og spiselige sammensetninger, legemidler og veterin¶rprodukter inneholdende denne
EP1634600A4 (en) ANTIALLERGIC COMPOSITION
NO931085L (no) Tarmkanal-koloniserende lactobasiller
AU2002350530A1 (en) Composition comprising a lactobacillus pentosus strain and uses thereof
PL342759A1 (en) Novel medium
IL143632A0 (en) Pharmaceutical compositions containing lactobacillus
CA2373255A1 (en) Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
AR086677A2 (es) Composicion de bacterias de acido lactico y su uso para hacer un suplemento alimentario de higiene o farmaceutica para la prevencion y/o tratamiento de infecciones y condiciones inflamatorias
SE9702083L (sv) Farmaceutisk beredning för bekämpning av patogena tarmbakterier
AU2001280178A1 (en) Probiotics products containing lactic acid bacterium
NZ518493A (en) Lactobacillus helvetius producing antihypertensive DI- and tripeptides
MXPA04000808A (es) Cepas probioticas de lactobacillus salivarius.
EP0986314A4 (en) PROBIOTIC MILKY ACID BACTERIUM FOR THE TREATMENT OF BACTERIAL INFECTIONS ASSOCIATED WITH SIDS
HK1079104A1 (en) Orally administrable composition to human for the photoprotection of the skin
JP2001519144A5 (no)
MY127895A (en) New lactic acid bacteria strains capable of preventing diarrhoea
FR2771600B1 (fr) Preparation de produits alimentaires par fermentation d'un melange de jus de soja et d'hydrolysat cerealier par streptococcus thermophilus
GR3032933T3 (en) Inhibition of clostridia with lactic acid bacteria
PL362374A1 (en) New strains of lactobacillus paracasei
ZA969111B (en) Lactic ferments and their use for the production of hypocholesterolaemic products.
AU2002362549A1 (en) Novel lactic acid bacteria of the genus lactococcus lactis and use thereof for preserving food products
RU2072692C1 (ru) Штамм бактерий lactobacillus helveticus, обладающий способностью снижать уровень холестерина в крови и используемый для получения препаратов и продуктов питания для профилактики и лечения гиперхолестеринемий
NO871988L (no) Fremgangsmaate til innsyring av groentfor.
SI0874718T1 (en) Use of an agent based on natural active substances for protecting technical materials against damages and destruction by harmful organisms
AU4630700A (en) Bacteria strain lactobacillus acidophilus N.V EP 317/402 (narine) AAA used in the production of preparations and of dietetic, therapeutic and prophylactic products for treating dysbacteriosis and the consequences thereof

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ACTIAL FARMACEUTICA S.R.L., IT

MM1K Lapsed by not paying the annual fees